ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Chino Hills, CA Author Works with Colleagues to Publish Second Edition of Textbook

By: PR Leap
(PRLeap.com) "Pharmacogenomics Book 2", a new book by Wen Yen Li (李文运), Bertram G. Katzung, MD, PhD, and Todd W Vanderah, has been released by Dorrance Publishing Co., Inc.

The most comprehensive, authoritative, and practical guide; the key to mastering and practicing the latest pharmacological concepts.
It uses hundreds of color images to illustrate drug actions and mechanisms. Basic and Clinical Pharmacology is a comprehensive and engaging medical guide that students have relied on for decades.
The content arrangement reflects the teaching sequence of many pharmacology courses and integrated disciplines, covering the important concepts students need to know about pharmacology and clinical practice. The original book has been on the market for 38 years, and the fifteenth edition has been extensively updated, with expanded coverage of drug transporters, pharmacogenomics, and drugs developed before 2019.

This book provides the knowledge and insight needed for excellence in all aspects of pharmacology.
Covers all aspects of medical pharmacology, including herbal medicines and over-the-counter drugs.

Major revisions have been made to immunopharmacology, anticonvulsants, antipsychotics, antidepressants, antidiabetic drugs, anti-inflammatory drugs and antiviral drugs, prostaglandins, and central nervous system transmitters.

New topics on cannabis pharmacology have been added.

Each chapter begins with a case study, covers various drugs and prototypes, and ends with summary tables and infographics.

Revised and brand-new color illustrations provide more explanations of drug actions and mechanisms, helping to clarify important concepts.

New and updated concepts cover information on currently discovered receptors, receptor mechanisms, and drug transporters.

Due to space limitations, the Chinese translation of this book is published in two volumes, providing high-quality and convenient academic resources for Chinese readers. It is suitable for medical and pharmaceutical college students, graduate students, and clinicians, and is also a useful textbook and reference book for those engaged in medical and pharmaceutical teaching, research, and technical-related personnel.


About the Authors:
Wen Li earned his degree in pharmacy at the Western China University of Medical Science in
Chengdu, the People's Republic of China. He has worked as a pharmacist, research associate,
and research specialist and published numerous articles for pharmacists worldwide.

译者:李文运,1962年四川医学院,药学系(现四川大学华西医科大学药学院) 毕业。曾在重庆
医学院从事药学和化学教学工作多年。1982年以访问学者 身份应邀到美国南加州大学药
学院进修"药物定量活性-结构关系"三年。 继后 先后在美国南加州大学药学院,加州大学爾
湾分校药理系工作,从事 药物合成,药代动力学,药理学等方面的研究二十多年。曾先后在药
物化学 杂誌( JMC), 制药科学杂誌 (J. Pharm. Sci. )等世界著名医学杂志上发表 研究论文十
余篇,并与南加州大学药学院药物化学教授Erick J. Lian 先生 共同编写"中药抗癌及化学构
造之关连"一书。

Dr. Bertram G. Katzung , MD, PhD received his M.D. in 1957 from State University of New York, Syracuse, and his Ph.D. in Pharmacology in 1962 from University of California, San Francisco (UCSF). He interned at Moffitt Hospital and joined UCSF's Department of Pharmacology and Experimental Therapeutics (now CMP) in 1958. He became a faculty member in 1962 and served as Acting Chair from 1978 to 1981. Dr. Katzung's research focused on cardiac cellular electrical activity and the effects of drugs, such as digitalis and antiarrhythmic agents, on cardiac function.

Todd W Vanderah, PhD, is a leading professor of pharmacology at the University of Arizona. He also plays an important role as Co-Director of the MD/PhD Dual Degree Program, which helps students pursue both medical and research degrees. Dr. Vanderah focuses his research on understanding how pain from cancer works and how the nervous system processes pain. He studies changes in the nerves that can lead to pain and how the body adapts to these changes. Additionally, he investigates how certain pain-relieving drugs work and looks for new ways to treat pain effectively.

"Pharmacogenomics Book 2"is a 644-page paperback with a retail price of $215.00 (eBook $210.00). The ISBN is 979-8-88729-347-9. Published by Dorrance Publishing Co., Inc. of Pittsburgh, Pennsylvania. For members of the press, to request a review copy or author interview, please visit https://bookstore.dorrancepublishing.com/pages/media-requests or to buy the book, visit our online bookstore at https://bookstore.dorrancepublishing.com/products/pharmacogenomics-book-2 . Book 1 is also available on our online bookstore at https://bookstore.dorrancepublishing.com/products/pharmacogenomics-book-1-%E5%9F%BA%E7%A1%80%E5%8F%8A%E4%B8%B4%E5%BA%8A%E8%8D%AF%E7%90%86%E5%AD%A6-%E7%AC%AC15%E4%B8%AD%E6%96%87%E7%BF%BB%E8%AF%91%E7%89%88-%E7%AC%AC1%E5%86%8C

GET IN TOUCH
Amanda Urso
Dorrance Publishing

http://www.dorrancepublishing.com

You can see the original version and more on PRLeap here: http://www.prleap.com/pr/304529/chino-hills-ca-author-works-with-colleagues-to-publish-second-edition-of-textbook

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.